Suppressing tumors with herb compounds | VR meets cardiology
- WEST LAFAYETTE, IN—While thyme and oregano contain a compound that can suppress tumor development, the amount of those you get through food is not enough to do that. Researchers at Purdue University may have found a way to use the compound in drug development.
- CINCINNATI, OH—Dr. Ryan Moore is a pediatric cardiologist at Cincinnati Children’s Hospital who also has a background in digital arts. He and his team have created advanced virtual reality (VR) technology that, just before Christmas, helped them heal a 12-year-old boy whose heart would not pump blood properly.
- ANN ARBOR, MI—The University of Michigan Academic Innovation Center, School of Nursing, and Faculty of Pharmacy have designed an innovative way to teach nursing and pharmacy students about the complexity of chemistry—through stimulation exercises with the Oculus Rift. The VR experience is called Under the Skin, and it helps students better understand what is happening at the cellular level.
- NASHVILLE, TN—Physician performance analytics company Embold Health raised $20 million in Series B funding led by Echo Health Ventures. Embold has built a suite of practice pattern and appropriateness metrics to power smarter health care decisions. The Series B investment will fuel Embold Health’s national expansion.
- KANSAS CITY, MO—Oracle Corporation has purchased health care technology company Cerner Corporation for $28.3 billion. Oracle plans to modernize Cerner’s systems and move them to the Oracle Cloud. This is Oracle’s largest acquisition since its purchase of NetSuite for $9.3 billion in 2016.
- CORALVILLE, IA—Integrated DNA Technologies won the Gold Award for Most Innovative New Product in the genomics category for its rhAMPSeq CRISPR analysis system. The system includes a cloud-based data analysis pipeline tool that produces publication-ready graphs and figures, thereby helping researchers eliminate the need for bioinformatics resources or expertise.